Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Fitxers

906908.pdf (4.88 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2025-08-05

Llicència de publicació

cc-by-nc (c) Fernández-Fernández, Julio et al., 2025
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/229769

Characterization and release modelling in ELR-based nanocomposite hydrogel loaded with polylactic acid for the implementation of a biomedical device

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1016/j.ijbiomac.2025.146552

Resum

Cardiac tissues are difficult to regenerate due to the low proliferative capacity of cardiomyocytes. A new therapeutic strategy for cardiac regenerative medicine could include a device capable of ensuring cell grafting, stimulating cardiac tissue regeneration, and serving as an appropriate scaffold for the controlled and sustained release of lactate over time as an inducer of cardiomyocyte proliferation. An effective source of lactate could consist of the lactic acid polymer (PLA) itself, which generates free lactic acid during its degradation. In this work, we have developed a nanocomposite hydrogel for lactate release based on a biocompatible and biodegradable matrix formed by elastin-like recombinamers cross-linked via click chemistry. Polylactic acid particles were encapsulated in the matrix after these particles had been partially degraded to lactic acid through oxygen plasma treatment. In the first 48 h, an early and modulated release of free lactic acid from plasma-treated PLA degradation is observed, and over longer periods, a sustained release of lactic acid produced by the hydrolytic degradation of PLA under physiological conditions occurs. Lactate is available from the very beginning (“early release”), addressing the drawback of the slow degradation (by hydrolysis) of polylactic acid. Therefore, a biomedical device has been designed and implemented, formed by an ELR polymeric matrix as an analogue of cardiac tissue, acting as a device for early, controlled, and sustained lactate release, with dosing at concentrations similar to those previously studied as suitable for promoting cardiomyocyte proliferation, showing promise for its use in the regeneration of infarcted cardiac tissue.

Matèries

Malalties cardiovasculars, Biopolímers, Polímers en medicina

Matèries (anglès)

Cardiovascular diseases, Biopolymers, Polymers in medicine

Citació

Col·leccions

Articles publicats en revistes (Enginyeria Electrònica i Biomèdica)

Citació

FERNÁNDEZ-FERNÁNDEZ, Julio, et al. Characterization and release modelling in ELR-based nanocomposite hydrogel loaded with polylactic acid for the implementation of a biomedical device. International Journal of Biological Macromolecules. 2025. Vol. 321, num. 146552. ISSN 0141-8130. [consulted: 5 of August of 2026]. Available at: https://hdl.handle.net/2445/229769

Exportar metadades

JSON - METS

Compartir registre